Cipla beats Glaxo in race for anti-AIDS drug
Submitted by ipsita on Tue, 1997-12-09 10:30
The Rs 541-crore Cipla has introduced its indigenously developed anti-AIDS drug, lamivudine, in both the domestic and overseas market at less than half the prevailing global prices. Cipla's early
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
09/12/1997